• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯妥英钠对41例自幼入院治疗的癫痫患者的影响。

Effects of diphenylhydantoin in 41 epileptics institutionalized since childhood.

作者信息

Herberg K P

出版信息

South Med J. 1977 Jan;70(1):19-24. doi: 10.1097/00007611-197701000-00009.

DOI:10.1097/00007611-197701000-00009
PMID:190707
Abstract

Institutionalized epileptic patients on long-term anticonvulsant diphenylhydantoin (DPH) therapy were examined clinically. DPH plasma levels were unexpectedly high in 54% despite rather poor seizure control. No patient was free from side effects, which included gingival hypertrophy (90% of patients), increased alkaline phosphatase activity (55%), suggestion of a sensory peripheral neuropathy (34%), central nervous system (CNS) intoxication (22%), coarsened facial features (19%), tendency to bleed excessively (15%), hirsutism (12%), and mild megalocytic anemia (5%). CNS intoxication correlated with high plasma DPH levels, reports of deteriorating behavioral and motor performance, and the findings of nystagmus on vertical gaze or truncal ataxia, though not all patients with high plasma levels were clinically intoxicated. Alarming were the often disfiguring changes of gums and facial structures and the tendency to develop signs of vitamin D deficiency secondary to therapy. Hirsutism was rare in black patients. Plasma DPH level determinations are recommended as part of the management of mentally retarded epileptic patients but do not replace clinical acumen and skill.

摘要

对长期接受抗惊厥药物苯妥英钠(DPH)治疗的住院癫痫患者进行了临床检查。尽管癫痫控制效果相当差,但54%的患者DPH血浆水平意外升高。无一例患者无副作用,副作用包括牙龈增生(90%的患者)、碱性磷酸酶活性升高(55%)、提示感觉性周围神经病(34%)、中枢神经系统(CNS)中毒(22%)、面部特征变粗(19%)、出血倾向增加(15%)、多毛症(12%)和轻度巨细胞性贫血(5%)。CNS中毒与高血浆DPH水平、行为和运动表现恶化的报告以及垂直注视时眼球震颤或躯干共济失调的发现相关,尽管并非所有血浆水平高的患者临床上都有中毒表现。令人担忧的是牙龈和面部结构经常出现毁容性变化以及治疗继发维生素D缺乏迹象的倾向。多毛症在黑人患者中很少见。建议测定血浆DPH水平作为智力发育迟缓癫痫患者管理的一部分,但不能取代临床敏锐度和技能。

相似文献

1
Effects of diphenylhydantoin in 41 epileptics institutionalized since childhood.苯妥英钠对41例自幼入院治疗的癫痫患者的影响。
South Med J. 1977 Jan;70(1):19-24. doi: 10.1097/00007611-197701000-00009.
2
Side effects of antiepileptic drugs: a peripheral neuropathy due to diphenylhydantoin (DPH) intoxication.抗癫痫药物的副作用:由苯妥英(DPH)中毒引起的周围神经病变。
Folia Psychiatr Neurol Jpn. 1980;34(3):314-5. doi: 10.1111/j.1440-1819.1980.tb01549.x.
3
Problems with the use of conventional anticonvulsant drugs in mentally retarded individuals.在智力迟钝个体中使用传统抗惊厥药物的问题。
Brain Dev. 1979;1(2):77-82.
4
Cerebellar atrophy in phenytoin-treated mentally retarded epileptics.
Epilepsia. 1977 Sep;18(3):375-86. doi: 10.1111/j.1528-1157.1977.tb04980.x.
5
Electroencephalography and phenytoin toxicity in mentally retarded epileptic patients.智障癫痫患者的脑电图与苯妥英钠毒性
J Neurol Neurosurg Psychiatry. 1978 Mar;41(3):272-7. doi: 10.1136/jnnp.41.3.272.
6
Plasma level distribution, effect and toxicity of antiepileptic drugs among Ethiopian epileptics.
Ethiop Med J. 1990 Jan;28(1):23-30.
7
Chronic diphenyl hydantoin encephalopathy in mentally retarded children and adolescent with severe epilepsy.患有严重癫痫的智障儿童和青少年中的慢性苯妥英脑病。
Acta Neurol Scand. 1979 Jul;60(1):50-5. doi: 10.1111/j.1600-0404.1979.tb02950.x.
8
Effect of diphenylhydantoin therapy on folate metabolism of mentally retarded epileptics.苯妥英治疗对智障癫痫患者叶酸代谢的影响。
Tohoku J Exp Med. 1973 May;110(1):59-68. doi: 10.1620/tjem.110.59.
9
Transient hyperkinesia after a single intravenous perfusion of diphenylhydantoin. Report of a case associated with nontoxic plasma levels of diphenylhydantoin.单次静脉注射苯妥英钠后的短暂性运动增多症。一例血浆苯妥英钠水平无毒情况下的病例报告。
Eur Neurol. 1979;18(2):116-23. doi: 10.1159/000115065.
10
Diphenylhydantoin as an anticonvulsant: protein binding and fluctuation of the serum and cerebrospinal fluid levels in forty mentally subnormal epileptics.
J Ment Defic Res. 1969 Dec;13(4):235-44. doi: 10.1111/j.1365-2788.1969.tb01087.x.